Manufacturers across Brazil, China, India, Indonesia, Malaysia, Nigeria, Uganda, Ukraine and Vietnam sign sublicence agreements to develop and manufacture generic versions of Roche’s baloxavir marboxil under MPP’s voluntary licence, helping diversify manufacturing capacity and strengthen pandemic preparedness.    New York – The Medicines Patent Pool (MPP) today announced the signing of sublicence agreements with eleven manufacturers across nine countries to develop and manufacture generic versions … Continue reading MPP signs sublicence agreements with generic manufacturers to expand access to influenza treatment and strengthen pandemic preparedness